SCs share the opportunity to have an impact on the cannabinoid receptors (CB1 and CB2) in the human body, mimicking the results of tetrahydrocannabinol (THC), the main psychoactive component of cannabis. These substances are really efficacious and work as agonists at cannabinoid receptors, when THC is just a partial agonist. The extreme potency of